Main Menu

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Take a short survey to help improve our website, find out about how philanthropy supports our research, or meet some of our employees.

Back to top
  • Clinical trial leads the way to side-stepping side effects using state of the art radiotherapy

    Clinical trial leads the way to side-stepping side effects using state of the art radiotherapy

    A major clinical trial has shown that changing the way radiotherapy is delivered could significantly reduce the side effects associated with radiotherapy treatment for prostate cancer.

    Read more
  • The Art of Science – Cutting edge science and captivating images

    The Art of Science – Cutting edge science and captivating images

    Researchers from the ICR and The Royal Marsden submitted fantastic images to this year’s ICR Science and Medical Imaging competition, with winning images by PhD student Sumana Shrestha showcasing just how captivating scientific and medical images can be.

    Read more
  • Let’s finish it: help us revolutionise cancer treatment

    Let’s finish it: help us revolutionise cancer treatment

    We aim to discover a new generation of cancer treatments so smart and targeted, that more patients will defeat their cancer and finish what they started.

    Support us
  • 'Genetic rewiring' drives cancer’s drug resistance

    'Genetic rewiring' drives cancer’s drug resistance

    A tiny molecule of RNA – known as ‘microRNA’ – plays a key role in ‘rewiring’ cancer cells so they can resist the effects of chemotherapy, a new study reveals. The discovery opens up the possibility of creating new cancer drugs that target this microRNA molecule.

    Read more
  • Ageing, cancer, and evolution – what Darwin’s great theory of life means for two unavoidable aspects of living

    Ageing, cancer, and evolution – what Darwin’s great theory of life means for two unavoidable aspects of living

    To celebrate Darwin Day, the ICR invited world-leading expert on the biology of ageing, Professor Dame Linda Partridge, to talk about how ageing stems from evolutionary processes and what it means for diseases like cancer.

    Read more
  • Fit to burst: How cancer-exploding viruses are changing the game

    Fit to burst: How cancer-exploding viruses are changing the game

    Oncolytic viruses are viruses which can burst cancer cells. In this feature, Joanne Duffy takes a look at what ICR researchers are doing in this realm, and how oncolytic viruses can help us target cancer more effectively.

    Read more
1/6

Let’s finish it: help us revolutionise cancer treatment

Help us discover a new generation of cancer treatments so smart and targeted, that more patients will defeat their cancer and finish what they started.

Find out more

How we work with industry

We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.

Find out more

Our scientific discoveries

For more than 100 years, the ICR has played an important role in shaping understanding of cancer and how it can be treated.

Find out more

The Drug Discoverer

Our Chief Executive and President, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.

Find out more

Share your story

We always want to hear from people who have a cancer story to share. Get in touch and help raise awareness of our research.

Find out more

Philanthropy

Philanthropy has played a key role in the progress we have made over the years and there are many opportunities to play a part in the future of cancer research.

Find out more